156 related articles for article (PubMed ID: 31772678)
1. Association between gene methylation and HBV infection in hepatocellular carcinoma: A meta-analysis.
Zhang C; Huang C; Sui X; Zhong X; Yang W; Hu X; Li Y
J Cancer; 2019; 10(25):6457-6465. PubMed ID: 31772678
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.
Zhang C; Li J; Huang T; Duan S; Dai D; Jiang D; Sui X; Li D; Chen Y; Ding F; Huang C; Chen G; Wang K
Oncotarget; 2016 Dec; 7(49):81255-81267. PubMed ID: 27835605
[TBL] [Abstract][Full Text] [Related]
3. Association of GSTP1 and P16 promoter methylation with the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
Li Q; Deng C; Zhang T; Li X
Onco Targets Ther; 2018; 11():5789-5796. PubMed ID: 30254471
[TBL] [Abstract][Full Text] [Related]
4. Contribution of DNA methylation to the risk of hepatitis C virus-associated hepatocellular carcinoma: A meta-analysis.
Zhang C; Zhang W; Yuan Z; Yang W; Hu X; Duan S; Wei Q
Pathol Res Pract; 2022 Oct; 238():154136. PubMed ID: 36155324
[TBL] [Abstract][Full Text] [Related]
5. Detecting abnormal methylation of tumor suppressor genes
Qu Z; Jiang Y; Li H; Yu DC; Ding YT
Oncol Lett; 2015 Oct; 10(4):2553-2558. PubMed ID: 26622888
[TBL] [Abstract][Full Text] [Related]
6. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
7. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.
Nishida N; Nagasaka T; Nishimura T; Ikai I; Boland CR; Goel A
Hepatology; 2008 Mar; 47(3):908-18. PubMed ID: 18161048
[TBL] [Abstract][Full Text] [Related]
9. Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma.
Jicai Z; Zongtao Y; Jun L; Haiping L; Jianmin W; Lihua H
Mol Carcinog; 2006 Jul; 45(7):530-6. PubMed ID: 16649250
[TBL] [Abstract][Full Text] [Related]
10. Association of APC, GSTP1 and SOCS1 promoter methylation with the risk of hepatocellular carcinoma: a meta-analysis.
Liu M; Cui LH; Li CC; Zhang L
Eur J Cancer Prev; 2015 Nov; 24(6):470-83. PubMed ID: 25853848
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.
Rongrui L; Na H; Zongfang L; Fanpu J; Shiwen J
Curr Pharm Des; 2014; 20(11):1715-25. PubMed ID: 23888939
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Dong X; Hou Q; Chen Y; Wang X
Dis Markers; 2017; 2017():2929381. PubMed ID: 28951629
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
Lambert MP; Paliwal A; Vaissière T; Chemin I; Zoulim F; Tommasino M; Hainaut P; Sylla B; Scoazec JY; Tost J; Herceg Z
J Hepatol; 2011 Apr; 54(4):705-15. PubMed ID: 21146512
[TBL] [Abstract][Full Text] [Related]
15. SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.
Zhang X; You Q; Zhang X; Chen X
Int J Mol Sci; 2015 Sep; 16(9):22662-75. PubMed ID: 26393582
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
17. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
18. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection.
Narimatsu T; Tamori A; Koh N; Kubo S; Hirohashi K; Yano Y; Arakawa T; Otani S; Nishiguchi S
Intervirology; 2004; 47(1):26-31. PubMed ID: 15044833
[TBL] [Abstract][Full Text] [Related]
19. Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status.
Song MA; Kwee SA; Tiirikainen M; Hernandez BY; Okimoto G; Tsai NC; Wong LL; Yu H
Epigenetics; 2016 Jun; 11(6):464-74. PubMed ID: 27248055
[TBL] [Abstract][Full Text] [Related]
20. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.
Huang J; Wang Y; Guo Y; Sun S
Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]